Sekine Y. Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese. Japanese journal of clinical oncology. 2022. 52. 12. 1441-1445
Numakura K. Factors influencing warm ischemia time in robot-assisted partial nephrectomy change depending on the surgeon’s experience. World Journal of Surgical Oncology. 2022. 20. 1
Yagishita H. Effects of NR1I2 and ABCB1 Genetic Polymorphisms on Everolimus Pharmacokinetics in Japanese Renal Transplant Patients. International Journal of Molecular Sciences. 2022. 23. 19
Inoue T. Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Guérin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From the Japanese Urological Oncology Research Group JUOG-UC-1901-BCG. Urology. 2022. 167. 158-164
Sasaki Y. A Case of Renal Anastomosing Hemangioma. Hinyokika kiyo. Acta urologica Japonica. 2022. 68. 8. 265-269
Tomita Y. Erratum: Subgroup analysis of the AFTER I-O study: A retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma (Japanese Journal of Clinical Oncology (2021) DOI: 10.1093/jjco/hyab114). Japanese Journal of Clinical Oncology. 2021. 51. 12